NASDAQ : ZYBT
Zhengye Biotechnology Holding Limited — Financial statements
Healthcare · Drug Manufacturers - Specialty & Generic · China
Last price 1.43 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 67.77M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Zhengye Biotechnology Holding Limited (ZYBT) reported revenue of 116.36M CNY (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in CNY.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 116.36M | 116.36M | 186.36M | 211.65M | 260.27M | 214.07M |
| Cost of Revenue | 92.49M | 92.49M | 95.06M | 94.14M | 112.39M | 89.45M |
| Gross Profit | 23.87M | 23.87M | 91.30M | 117.51M | 147.88M | 124.62M |
| Selling, General & Admin | 74.92M | 74.92M | 63.84M | 64.33M | 58.89M | 58.86M |
| Research & Development | 18.01M | 18.01M | 12.79M | 11.90M | 13.42M | 11.37M |
| Operating Expenses | 94.38M | 94.38M | 74.86M | 72.52M | 82.05M | 72.16M |
| Operating Income | -70.51M | -70.51M | 16.44M | 44.99M | 65.83M | 52.47M |
| Interest Expense | -3.40M | -3.40M | -4.04M | -4.42M | -2.84M | -1.05M |
| Interest & Investment Income | 96.00K | 96.00K | 231.00K | 312.00K | 114.00K | 112.00K |
| Currency Exchange Gain (Loss) | -312.00K | -312.00K | 679.00K | |||
| Other Non Operating Income (Expenses) | 2.12M | 2.12M | 879.00K | 2.89M | 805.00K | 1.62M |
| EBT Excluding Unusual Items | -72.00M | -72.00M | 14.19M | 43.76M | 63.91M | 53.15M |
| Gain (Loss) on Sale of Investments | 127.00K | 127.00K | 209.00K | |||
| Asset Writedown | -83.00K | |||||
| Pretax Income | -71.87M | -71.87M | 14.39M | 43.76M | 63.91M | 53.07M |
| Income Tax Expense | 11.10M | 11.10M | 924.00K | 6.25M | 8.17M | 6.60M |
| Earnings From Continuing Operations | -82.97M | -82.97M | 13.47M | 37.51M | 55.74M | 46.47M |
| Minority Interest in Earnings | 13.18M | 13.18M | -2.16M | -6.05M | -9.01M | -7.51M |
| Net Income | -69.78M | -69.78M | 11.31M | 31.46M | 46.73M | 38.96M |
| Net Income to Common | -69.78M | -69.78M | 11.31M | 31.46M | 46.73M | 38.96M |
| Shares Outstanding (Basic) | 47.35M | 47.35M | 45.67M | 45.67M | 45.67M | 45.67M |
| Shares Outstanding (Diluted) | 47.35M | 47.35M | 45.67M | 45.67M | 45.67M | 45.67M |
| EPS (Basic) | -1.47 | -1.47 | 0.25 | 0.69 | 1.02 | 0.85 |
| EPS (Diluted) | -1.47 | -1.47 | 0.25 | 0.69 | 1.02 | 0.85 |
| Free Cash Flow | 12.32M | 12.32M | 27.46M | 40.79M | -9.99M | 12.75M |
| Free Cash Flow Per Share | 0.26 | 0.26 | 0.60 | 0.89 | -0.22 | 0.28 |
| Gross Margin | 20.51% | 20.51% | 48.99% | 55.52% | 56.82% | 58.22% |
| Operating Margin | -60.59% | -60.59% | 8.82% | 21.25% | 25.30% | 24.51% |
| Profit Margin | -59.97% | -59.97% | 6.07% | 14.86% | 17.96% | 18.20% |
| Free Cash Flow Margin | 10.59% | 10.59% | 14.74% | 19.27% | -3.84% | 5.96% |
| EBITDA | -44.62M | -44.62M | 40.60M | 68.90M | 84.63M | 68.48M |
| EBITDA Margin | -38.35% | -38.35% | 21.79% | 32.55% | 32.52% | 31.99% |
| D&A For EBITDA | 25.88M | 25.88M | 24.16M | 23.91M | 18.80M | 16.01M |
| EBIT | -70.51M | -70.51M | 16.44M | 44.99M | 65.83M | 52.47M |
| EBIT Margin | -60.59% | -60.59% | 8.82% | 21.25% | 25.29% | 24.51% |
| Effective Tax Rate | 6.42% | 14.29% | 12.79% | 12.44% | ||
| Advertising Expenses | 1.72M | 1.72M | 1.54M | 2.54M | 2.58M | 2.23M |
Balance sheet
Fiscal year January - December; amounts in CNY.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 50.33M | 50.33M | 18.60M | 15.07M | 9.75M | 6.28M |
| Short-Term Investments | 1.56M | 1.56M | 1.43M | 1.22M | ||
| Cash & Short-Term Investments | 51.89M | 51.89M | 20.04M | 16.30M | 9.75M | 6.28M |
| Accounts Receivable | 18.48M | 18.48M | 85.16M | 97.38M | 133.58M | 101.47M |
| Other Receivables | 738.00K | 2.04M | 672.00K | 722.00K | ||
| Receivables | 18.48M | 18.48M | 85.89M | 99.42M | 134.25M | 102.19M |
| Inventory | 39.17M | 39.17M | 58.22M | 58.30M | 55.42M | 43.62M |
| Prepaid Expenses | 16.38M | 16.38M | ||||
| Restricted Cash | 2.00K | 2.00K | 2.00K | 12.11M | ||
| Other Current Assets | 11.50M | 11.50M | 13.41M | 3.11M | 2.43M | 1.71M |
| Total Current Assets | 137.42M | 137.42M | 177.57M | 189.24M | 214.31M | 164.94M |
| Property, Plant & Equipment | 237.28M | 237.28M | 255.16M | 263.25M | 275.23M | 246.41M |
| Other Intangible Assets | 54.76M | 54.76M | 22.78M | 24.48M | 27.90M | 20.75M |
| Long-Term Deferred Tax Assets | 10.99M | 11.91M | ||||
| Long-Term Deferred Charges | 8.05M | 4.50M | ||||
| Other Long-Term Assets | 7.01M | 7.01M | 18.70M | 6.50M | 2.23M | 13.17M |
| Total Assets | 436.47M | 436.47M | 493.25M | 499.89M | 519.67M | 445.28M |
| Accounts Payable | 44.01M | 44.01M | 42.96M | 45.66M | 79.28M | 77.57M |
| Accrued Expenses | 646.00K | 646.00K | 801.00K | 536.00K | 573.00K | 604.00K |
| Short-Term Debt | 65.10M | 65.10M | 74.59M | 79.86M | 54.89M | 30.00M |
| Current Portion of Long-Term Debt | 700.00K | 700.00K | 7.19M | |||
| Current Portion of Leases | 106.00K | 106.00K | ||||
| Current Income Taxes Payable | 2.35M | 2.35M | 2.07M | 2.29M | 10.00M | 6.81M |
| Current Unearned Revenue | 4.83M | 4.83M | 3.69M | 3.98M | 4.70M | 4.28M |
| Other Current Liabilities | 2.74M | 2.74M | 4.62M | 17.90M | 2.79M | 6.37M |
| Total Current Liabilities | 120.48M | 120.48M | 135.91M | 150.23M | 152.23M | 125.63M |
| Long-Term Debt | 8.85M | 8.85M | 4.80M | 9.99M | 9.99M | |
| Long-Term Leases | 327.00K | 327.00K | ||||
| Long-Term Deferred Tax Liabilities | 104.00K | 104.00K | ||||
| Other Long-Term Liabilities | 393.00K | 590.00K | 816.00K | |||
| Total Liabilities | 129.76M | 129.76M | 140.71M | 160.62M | 162.81M | 126.44M |
| Common Stock | 8.00K | 8.00K | 8.00K | 8.00K | 8.00K | 8.00K |
| Additional Paid-In Capital | 240.75M | 240.75M | 203.15M | 203.15M | 203.15M | 203.15M |
| Retained Earnings | 11.01M | 11.01M | 80.80M | 69.69M | 93.34M | 64.32M |
| Comprehensive Income & Other | -1.93M | -1.93M | 3.00K | |||
| Total Common Equity | 249.85M | 249.85M | 283.96M | 272.85M | 296.50M | 267.47M |
| Minority Interest | 56.87M | 56.87M | 68.58M | 66.42M | 60.37M | 51.36M |
| Shareholders' Equity | 306.71M | 306.71M | 352.54M | 339.27M | 356.87M | 318.84M |
| Total Liabilities & Equity | 436.47M | 436.47M | 493.25M | 499.89M | 519.67M | 445.28M |
| Total Debt | 75.08M | 75.08M | 86.58M | 89.85M | 64.88M | 30.00M |
| Net Cash (Debt) | -23.19M | -23.19M | -66.54M | -73.55M | -55.13M | -23.72M |
| Net Cash Per Share | -0.49 | -0.49 | -1.46 | -1.61 | -1.21 | -0.52 |
| Filing Date Shares Outstanding | 47.39M | 47.39M | 47.39M | 45.67M | 45.67M | 45.67M |
| Total Common Shares Outstanding | 47.39M | 47.39M | 45.67M | 45.67M | 45.67M | 45.67M |
| Working Capital | 16.94M | 16.94M | 41.66M | 39.01M | 62.08M | 39.32M |
| Book Value Per Share | 5.27 | 5.27 | 6.22 | 5.97 | 6.49 | 5.86 |
| Tangible Book Value | 195.09M | 195.09M | 261.18M | 248.37M | 268.59M | 246.72M |
| Tangible Book Value Per Share | 4.12 | 4.12 | 5.72 | 5.44 | 5.88 | 5.40 |
| Buildings | 217.14M | 217.14M | 205.43M | 197.19M | 119.79M | 166.90M |
| Machinery | 150.84M | 150.84M | 151.54M | 151.04M | 146.74M | 118.00M |
| Construction In Progress | 610.00K | 610.00K | 9.75M | 7.62M | 82.06M | 52.76M |
Cash flow statement
Fiscal year January - December; amounts in CNY.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -69.78M | -69.78M | 11.31M | 31.46M | 46.73M | 38.96M |
| Depreciation & Amortization | 25.95M | 25.95M | 24.16M | 23.91M | 18.80M | 16.01M |
| Loss (Gain) From Sale of Assets | 174.00K | 187.00K | -53.00K | |||
| Asset Writedown & Restructuring Costs | 83.00K | |||||
| Loss (Gain) From Sale of Investments | -127.00K | -127.00K | -209.00K | |||
| Provision & Write-off of Bad Debts | 1.44M | 1.44M | -1.78M | -3.71M | 9.73M | 1.93M |
| Other Operating Activities | 11.02M | 11.02M | 8.37M | 16.62M | 8.66M | 8.59M |
| Change in Accounts Receivable | 39.71M | 39.71M | 16.34M | 31.04M | -24.72M | -28.50M |
| Change in Inventory | 8.23M | 8.23M | -13.56M | -13.52M | -13.04M | -12.60M |
| Change in Accounts Payable | -3.36M | -3.36M | -404.00K | -35.61M | -9.67M | 17.63M |
| Change in Unearned Revenue | 1.27M | 1.27M | -400.00K | -715.00K | 317.00K | 1.40M |
| Change in Income Taxes | 279.00K | 279.00K | -229.00K | -7.70M | 3.19M | 801.00K |
| Change in Other Net Operating Assets | -1.30M | -1.30M | -2.73M | 6.23M | -22.67M | -12.44M |
| Operating Cash Flow | 13.33M | 13.33M | 41.05M | 48.18M | 17.34M | 31.81M |
| Capital Expenditures | -1.01M | -1.01M | -13.59M | -7.40M | -27.33M | -19.06M |
| Sale of Property, Plant & Equipment | 108.00K | 1.06M | 128.00K | |||
| Sale (Purchase) of Intangibles | -11.62M | -11.62M | -14.19M | -4.20M | -7.34M | |
| Investment in Securities | -1.22M | |||||
| Investing Cash Flow | -12.63M | -12.63M | -27.66M | -11.77M | -27.33M | -26.27M |
| Short-Term Debt Issued | 146.00K | |||||
| Long-Term Debt Issued | 70.47M | 70.47M | 90.12M | 79.86M | 99.85M | 30.00M |
| Total Debt Issued | 70.47M | 70.47M | 90.27M | 79.86M | 99.85M | 30.00M |
| Short-Term Debt Repaid | -146.00K | -146.00K | ||||
| Long-Term Debt Repaid | -82.56M | -82.56M | -92.86M | -54.89M | -64.97M | -22.00M |
| Total Debt Repaid | -82.71M | -82.71M | -92.86M | -54.89M | -64.97M | -22.00M |
| Net Debt Issued (Repaid) | -12.24M | -12.24M | -2.59M | 24.97M | 34.88M | 8.00M |
| Issuance of Common Stock | 44.55M | 44.55M | ||||
| Common Dividends Paid | -16.02M | -39.45M | -21.43M | -11.05M | ||
| Other Financing Activities | -3.51M | -4.50M | ||||
| Financing Cash Flow | 32.31M | 32.31M | -22.13M | -18.98M | 13.46M | -3.05M |
| Foreign Exchange Rate Adjustments | -1.28M | -1.28M | 168.00K | |||
| Net Cash Flow | 31.73M | 31.73M | -8.58M | 17.44M | 3.46M | 2.49M |
| Free Cash Flow | 12.32M | 12.32M | 27.46M | 40.79M | -9.99M | 12.75M |
| Free Cash Flow Margin | 10.59% | 10.59% | 14.74% | 19.27% | -3.84% | 5.96% |
| Free Cash Flow Per Share | 0.26 | 0.26 | 0.60 | 0.89 | -0.22 | 0.28 |
| Levered Free Cash Flow | 39.58M | 39.58M | 3.31M | 42.32M | -13.35M | |
| Unlevered Free Cash Flow | 41.70M | 41.70M | 5.83M | 45.08M | -11.57M | |
| Cash Interest Paid | 3.36M | 3.36M | 3.98M | 4.42M | 2.84M | 1.05M |
| Cash Income Tax Paid | 116.00K | 10.49M | 8.48M | 6.99M | ||
| Change in Working Capital | 44.83M | 44.83M | -977.00K | -20.28M | -66.60M | -33.71M |
Ratios
Fiscal year January - December; amounts in CNY.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 61.61M | 54.50M | ||||
| Enterprise Value | 64.92M | 69.06M | ||||
| Last Close Price | 1.30 | 1.15 | ||||
| PS Ratio | 3.70 | 3.28 | ||||
| PB Ratio | 1.72 | 1.24 | ||||
| P/TBV Ratio | 2.21 | 1.95 | ||||
| P/FCF Ratio | 33.28 | 30.93 | ||||
| P/OCF Ratio | 30.76 | 28.59 | ||||
| EV/Sales Ratio | 3.90 | 4.15 | ||||
| EV/FCF Ratio | 35.07 | 39.19 | ||||
| Debt / Equity Ratio | 0.24 | 0.24 | 0.25 | 0.27 | 0.18 | 0.09 |
| Debt / EBITDA Ratio | 2.13 | 1.30 | 0.77 | 0.44 | ||
| Debt / FCF Ratio | 6.09 | 6.09 | 3.15 | 2.20 | 2.35 | |
| Net Debt / Equity Ratio | 0.08 | 0.08 | 0.19 | 0.22 | 0.15 | 0.07 |
| Net Debt / EBITDA Ratio | -0.52 | -0.52 | 1.64 | 1.07 | 0.65 | 0.35 |
| Net Debt / FCF Ratio | 1.88 | 1.88 | 2.42 | 1.80 | -5.52 | 1.86 |
| Asset Turnover | 0.25 | 0.25 | 0.38 | 0.41 | 0.54 | |
| Inventory Turnover | 1.90 | 1.90 | 1.63 | 1.66 | 2.27 | |
| Quick Ratio | 0.58 | 0.58 | 0.78 | 0.77 | 0.95 | 0.86 |
| Current Ratio | 1.14 | 1.14 | 1.31 | 1.26 | 1.41 | 1.31 |
| Return on Equity (ROE) | -25.17% | -25.17% | 3.89% | 10.78% | 16.50% | |
| Return on Assets (ROA) | -9.48% | -9.48% | 2.07% | 5.51% | 8.53% | |
| Return on Invested Capital (ROIC) | -21.37% | -18.83% | 3.70% | 9.35% | 15.22% | 13.41% |
| Return on Capital Employed (ROCE) | -22.30% | -22.30% | 4.60% | 12.90% | 17.90% | 16.40% |
| Earnings Yield | -16.21% | -18.31% | ||||
| FCF Yield | 3.00% | 3.23% | ||||
| Payout Ratio | 141.66% | 125.42% | 45.84% | 28.36% | ||
| Buyback Yield / Dilution | -3.69% | -3.69% |